Jason Krikorian - Jun 16, 2022 Form 4 Insider Report for Augmedix, Inc. (AUGX)

Role
Director, 10%+ Owner
Signature
/s/ Paul Ginocchio, Attorney-in-Fact
Stock symbol
AUGX
Transactions as of
Jun 16, 2022
Transactions value $
$0
Form type
4
Date filed
6/21/2022, 08:04 PM
Previous filing
Jun 10, 2022
Next filing
Jul 8, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUGX Restricted Stock Units Award $0 +52.6K $0.00 52.6K Jun 16, 2022 Common Stock 52.6K $1.90 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Stock Unit ("RSU") is granted under the Augmedix, Inc. (the "Issuer") 2020 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer's common stock.
F2 The RSU will vest in full on the one-year anniversary of June 16, 2022, so long as the Reporting Person remains a director on such date.